Literature DB >> 10201460

Does this patient have Barrett's esophagus? The utility of predicting Barrett's esophagus at the index endoscopy.

M A Eloubeidi1, D Provenzale.   

Abstract

OBJECTIVES: Few studies have evaluated the ability of the endoscopist to predict the presence of Barrett's esophagus (BE) at index endoscopy. The goals of this study were to determine the operating characteristics of endoscopy in diagnosing BE, and to determine the clinical and endoscopic predictors of BE in suspected BE patients at the index endoscopy.
METHODS: From September 1993 to October 1997, endoscopic reports were examined to identify patients with suspected BE. All esophageal pathology reports during the same period were evaluated for the presence of specialized intestinal metaplasia.
RESULTS: During the study period, 4053 endoscopies were performed on 2393 patients. Eight percent of all procedures were performed for suspected or confirmed BE. Fifty-three patients were known to have BE and thus their reports were excluded from this analysis. Five hundred seventy of the remaining patients had esophageal biopsies performed, and were included in this analysis. Among these 570 patients, 146 were suspected to have BE on endoscopy, while 424 were not suspected to have BE at the time of endoscopy. There were no differences among the two groups in terms of gender, race, and dyspepsia as an indication for the endoscopy. However, suspected BE patients were slightly younger and were more likely to have heartburn, but were less likely to have dysphagia as an indication for the endoscopy. The sensitivity and specificity of the endoscopists' assessments were 82% (95% confidence interval [CI], 72-92) and 81% (95% CI, 78-84), respectively. The positive predictive value and the negative predictive value were 34% and 97%, respectively. The positive likelihood ratio was 4.32 (95% CI, 3.49-5.31) and the negative likelihood ratio was 0.22 (95% CI, 0.13-0.38). Univariate analysis showed that endoscopists diagnosed BE in those with long-segment BE (LSBE) more accurately than in those with short-segment BE (SSBE) (55% vs 25% p = 0.001; odds ratio [OR] = 3.63, 95% CI, 1.71-7.70). Barrett's esophagus was correctly diagnosed in 38.5% of white patients but in only 14.7% of black patients (p = 0.01; OR = 3.63, 95% CI, 1.31-10.13). Multivariable logistic regression identified only the length of the columnar-appearing segment (p = 0.002; OR = 3.33, 95% CI, 1.54-7.17) and race (p = 0.08; OR = 2.31, 95% CI, 0.88-6.03) to be associated with the presence of BE on biopsy.
CONCLUSIONS: Barrett's esophagus is frequently suspected at endoscopy; SSBE was more frequently suspected than LSBE, but was correctly diagnosed only 25% of the time, versus 55% for LSBE. Endoscopists diagnosed BE with a sensitivity of 82% and a specificity of 81%. However, the positive predictive value was only 34%, whereas the negative predictive value was 97%. The length of the columnar-appearing segment is the strongest predictor of BE at endoscopy. Alternative methods are needed to better identify BE patients endoscopically, especially those with SSBE.

Entities:  

Mesh:

Year:  1999        PMID: 10201460     DOI: 10.1111/j.1572-0241.1999.990_m.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  33 in total

1.  Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus.

Authors:  P Sharma; A P Weston; M Topalovski; R Cherian; A Bhattacharyya; R E Sampliner
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

2.  Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study.

Authors:  P Malfertheiner; T Lind; S Willich; M Vieth; D Jaspersen; J Labenz; W Meyer-Sabellek; O Junghard; M Stolte
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

3.  Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography.

Authors:  John A Evans; Brett E Bouma; Jason Bressner; Milen Shishkov; Gregory Y Lauwers; Mari Mino-Kenudson; Norman S Nishioka; Guillermo J Tearney
Journal:  Gastrointest Endosc       Date:  2006-09-20       Impact factor: 9.427

Review 4.  Endocytoscopy in esophageal cancer.

Authors:  Yutaka Tomizawa; Hamza M Abdulla; Ganapathy A Prasad; Louis-Michel Wong Kee Song; Lori S Lutzke; Lynn S Borkenhagen; Kenneth K Wang
Journal:  Gastrointest Endosc Clin N Am       Date:  2009-04

5.  Assessment of the diagnostic performance and interobserver variability of endocytoscopy in Barrett's esophagus: a pilot ex-vivo study.

Authors:  Yutaka Tomizawa; Prasad G Iyer; Louis M Wongkeesong; Navtej S Buttar; Lori S Lutzke; Tsung-Teh Wu; Kenneth K Wang
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

Review 6.  The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.

Authors:  P Malfertheiner; U Peitz
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

Review 7.  American Gastroenterological Association technical review on the management of Barrett's esophagus.

Authors:  Stuart J Spechler; Prateek Sharma; Rhonda F Souza; John M Inadomi; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2011-03       Impact factor: 22.682

8.  Barrett's esophagus on repeat endoscopy: should we look more than once?

Authors:  Sarah Rodriguez; Nora Mattek; David Lieberman; Brian Fennerty; Glenn Eisen
Journal:  Am J Gastroenterol       Date:  2008-06-28       Impact factor: 10.864

9.  Prevalence of Barrett's esophagus in patients with moderate to severe erosive esophagitis.

Authors:  Nooman Gilani; Richard-D Gerkin; Francisco-C Ramirez; Shahina Hakim; Adam-C Randolph
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

10.  Esophageal-guided biopsy with volumetric laser endomicroscopy and laser cautery marking: a pilot clinical study.

Authors:  Melissa J Suter; Michalina J Gora; Gregory Y Lauwers; Thomas Arnason; Jenny Sauk; Kevin A Gallagher; Lauren Kava; Khay M Tan; Amna R Soomro; Timothy P Gallagher; Joseph A Gardecki; Brett E Bouma; Mireille Rosenberg; Norman S Nishioka; Guillermo J Tearney
Journal:  Gastrointest Endosc       Date:  2014-01-23       Impact factor: 9.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.